OncoMyx Therapeutics rallies $50m Series B
OncoMyx Therapeutics, an immuno-oncology platform company, has raised $50 million in Series B financing.
OncoMyx Therapeutics, an immuno-oncology platform company, has raised $50 million in Series B financing.
Copyright PEI Media
Not for publication, email or dissemination